Podcast 3
Screening, diagnosis, and guideline recommendations for AATD management
Episode 3. Early detection can reshape outcomes. Pavel Strnad and Marc Miravitlles highlight the importance – and challenges – of early diagnosis in alpha-1 antitrypsin deficiency, and how the timing of diagnosis can influence disease management. They review gold-standard guideline recommendations for screening and identifying individuals with alpha-1 antitrypsin deficiency genotypes, along with diagnostic approaches and tools for ongoing disease monitoring.
Sponsorship statement
Developed independently by EPG Health, which received educational funding from Takeda, awarded to EPG Health to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and MEDTHORITY. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco Joint Accreditation #4008163.
Professions in scope for this activity are listed below.
Physicians
Amedco LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.